KBC Group’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

KBC Group’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-32,127	Closed	-$5.55M	–	1453
2015 Q1	$5.55M	Buy	32,127 +24,487	+321%	+$3.59M	0.07%	294
2014 Q4	$878K	Buy	7,640 +1,986	+35%	+$241K	0.01%	789
2014 Q3	$883K	Sell	5,654 -576	-9%	-$83.5K	0.03%	566
2014 Q2	$769K	Hold	6,230	–	–	0.01%	807
2014 Q1	$645K	Hold	6,230	–	–	0.01%	766
2013 Q4	$561K	Hold	6,230	–	–	0.01%	813
2013 Q3	$417K	Hold	6,230	–	–	0.01%	845
2013 Q2	$412K	Buy	+6,230	New	+$356K	0.01%	851

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

KBC Group's SLXP Position: Q2 2015 in Review

KBC Group sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 32,127 shares — an estimated $5.55M sold.

KBC Group first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $5.55M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

KBC Group reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
KBC Group sold 32,127 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $5.55M.
KBC Group first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
KBC Group's SALIX PHARMACEUTICALS LTD DEL position peaked at $5.55M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on KBC Group's 13F filing for Q2 2015, filed 31 Jul 2015.